NEW YORK (360Dx) — Alere said yesterday that it has appealed a decision by the Centers for Medicare and Medicaid Services (CMS) to revoke the Medicare billing privileges of the diagnostic company's diabetes unit, Arriva Medical.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.